Kiromic BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	4	1	3	17	38	45	41
Market Cap Growth	-	-67.65%	-83.10%	-54.22%	-14.46%	9.82%	-
Enterprise Value	16	13	12	-7	28	43	40
PE Ratio	0.00	-0.05	-0.08	-0.68	-1.99	-11.90	-10.65
PB Ratio	0.00	-0.10	-0.51	0.64	3.36	22.54	153.14
P/FCF Ratio	0.00	-0.04	-0.10	-0.79	-5.03	-13.87	-17.74
P/OCF Ratio	0.00	-0.04	-0.12	-0.86	-6.23	-15.31	-18.87
EV/EBITDA Ratio	-0.82	-0.67	-0.40	0.30	-1.50	-11.80	-12.97
EV/EBIT Ratio	-0.71	-0.60	-0.38	0.29	-1.48	-11.52	-12.64
EV/FCF Ratio	-0.58	-0.62	-0.41	0.33	-3.76	-13.27	-17.57
Debt / Equity Ratio	-1.70	-1.70	-1.63	0.02	0.04	0	0
Debt / EBITDA Ratio	-1.03	-0.78	-0.32	-0.02	-0.02	-	-
Debt / FCF Ratio	-0.73	-0.73	-0.33	-0.02	-0.06	-	-
Quick Ratio	0.16	0.16	0.05	7.44	6.92	2.86	0.67
Current Ratio	0.22	0.22	0.13	7.94	7.32	3.03	0.92
Interest Coverage	-8.40	10.77	-186.87	-2109.48	-5817.24	-164.68	-5.03
Return on Equity (ROE)	240.29%	229.69%	661.18%	-93.90%	-169.01%	-189.51%	-1438.26%
Return on Assets (ROA)	-180.10%	-172.15%	-319.04%	-83.48%	-149.68%	-141.38%	-435.58%
Return on Capital (ROIC)	-310.50%	-310.50%	-855.80%	-92.66%	-162.27%	-187.24%	-1199.62%
Earnings Yield	-552.35%	-2193.79%	-1293.45%	-146.85%	-50.32%	-8.41%	-9.39%
FCF Yield	-540.15%	-2244.32%	-969.76%	-127.17%	-19.87%	-7.21%	-5.64%
Buyback Yield / Dilution	-101.57%	-101.57%	-43.07%	-153.41%	-16.14%	-9.82%	-
Total Shareholder Return	-101.57%	-101.57%	-43.07%	-153.41%	-16.14%	-9.82%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.